Panbela Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Panbela Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
  • Panbela Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.17M, a 8.68% increase year-over-year.
  • Panbela Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$29.1M, a 22.3% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$25.6M, a 24.8% increase from 2022.
  • Panbela Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$34.1M, a 241% decline from 2021.
  • Panbela Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$10M, a 74% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$29.1M -$7.17M +$681K +8.68% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$29.7M -$8.1M -$2.23M -37.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$27.5M -$6.73M -$1.87M -38.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$25.6M -$7.06M -$1.88M -36.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$23.8M -$7.85M -$4.22M -117% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$19.5M -$5.88M +$15.4M +72.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$34.9M -$4.86M -$856K -21.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$34.1M -$5.18M -$1.85M -55.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$32.2M -$3.62M -$1.41M -63.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$30.8M -$21.3M -$19.1M -856% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$11.8M -$4M -$1.76M -78.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$10M -$3.33M -$1.74M -109% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$8.27M -$2.21M -$214K -10.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$8.06M -$2.23M -$1.12M -102% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$6.94M -$2.25M -$1.18M -111% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$5.75M -$1.59M -$349K -28.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$5.41M -$2M -$654K -48.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.75M -$1.1M -$16K -1.47% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$4.74M -$1.07M -$413K -63.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$4.32M -$1.24M -$599K -93.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$3.72M -$1.34M -$425K -46.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$3.3M -$1.09M +$8K +0.73% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$3.31M -$653K +$585K +47.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$3.89M -$640K +$1.18M +64.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$5.07M -$917K +$128K +12.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$5.19M -$1.1M +$66K +5.68% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$5.26M -$1.24M +$756K +37.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$6.02M -$1.82M +$294K +13.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$6.31M -$1.05M +$90K +7.93% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$6.4M -$1.16M -$213K -22.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$6.19M -$1.99M -$1.02M -105% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$5.17M -$2.11M -$811K -62.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$4.36M -$1.14M -$365K -47.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$3.99M -$949K +$244K +20.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$4.24M -$975K +$1.21M +55.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$5.44M -$1.3M +$880K +40.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$6.32M -$770K +$344K +30.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$6.67M -$1.19M -$1.14M -2289% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$5.52M -$2.18M -$2.08M -2009% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$3.45M -$2.18M -$2.12M -3999% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$1.32M -$1.11M -$1.06M -1953% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$261K -$49.9K -$6.47K -14.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$254K -$103K -$60K -138% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$194K -$53.1K -$178K -143% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$16.3K -$54.3K -$137K -166% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $121K -$43.5K -$145K -143% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $265K -$43.5K -$17.4K -66.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-14
Q4 2012 $283K $125K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 $82.7K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $101K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$26.1K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.